BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33814448)

  • 1. Neoline Improves Memory Impairment and Reduces Amyloid-β Level and Tau Phosphorylation Through AMPK Activation in the Mouse Alzheimer's Disease Model.
    Liu QF; Kanmani S; Lee J; Kim GW; Jeon S; Koo BS
    J Alzheimers Dis; 2021; 81(2):507-516. PubMed ID: 33814448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    Choi Y; Jeong HJ; Liu QF; Oh ST; Koo BS; Kim Y; Chung IW; Kim YS; Jeon S
    Mol Neurobiol; 2017 Jan; 54(1):450-460. PubMed ID: 26742522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits.
    Shah SA; Yoon GH; Chung SS; Abid MN; Kim TH; Lee HY; Kim MO
    Mol Psychiatry; 2017 Mar; 22(3):407-416. PubMed ID: 27001618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
    Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
    Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
    Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
    Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
    Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
    Yu CJ; Liu W; Chen HY; Wang L; Zhang ZR
    Cell Biochem Funct; 2014 Oct; 32(7):590-6. PubMed ID: 25230339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
    Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer׳s disease through Akt/CREB and GSK-3β phosphorylation in the brain.
    Jeon S; Park JE; Lee J; Liu QF; Jeong HJ; Pak SC; Yi S; Kim MH; Kim CW; Park JK; Kim GW; Koo BS
    J Ethnopharmacol; 2015 Feb; 160():69-77. PubMed ID: 25457987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tianma-Gouteng pair ameliorates the cognitive deficits on two transgenic mouse models of Alzheimer's disease.
    Zhong M; Xu QQ; Hu Z; Yang W; Lin ZX; Xian YF
    J Ethnopharmacol; 2024 Jun; 328():118113. PubMed ID: 38548119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
    Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of AMPK Ameliorates Alzheimer's Disease-Like Tau Pathology and Memory Impairment.
    Wang L; Li N; Shi FX; Xu WQ; Cao Y; Lei Y; Wang JZ; Tian Q; Zhou XW
    Mol Neurobiol; 2020 Aug; 57(8):3349-3361. PubMed ID: 32519244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing.
    Inestrosa NC; Tapia-Rojas C; Griffith TN; Carvajal FJ; Benito MJ; Rivera-Dictter A; Alvarez AR; Serrano FG; Hancke JL; Burgos PV; Parodi J; Varela-Nallar L
    Transl Psychiatry; 2011 Jul; 1(7):e20. PubMed ID: 22832522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
    Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
    Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.